Erratum: Optical coherence tomography in tamoxifen retinopathy (Breast Cancer Research and Treatment DOI: 10.1007/s10549-006-9187-y);Optical coherence tomography in tamoxifen retinopathy

Breast Cancer Research and Treatment

Volumn 99, Issue 1, 2006, Pages 117-118

  Martine, Mauget Faÿsse ^a   Joël, Gambrelle ^a   Maddalena, Quaranta El Maftouhi ^a  

^a Centre d'Ophtalmologie Rabelais   (France)

Author keywords

Foveolar pseudo cyst; Optical coherence tomography; Tamoxifen retinopathy

Indexed keywords

TAMOXIFEN;

ANALYTIC METHOD; ARTICLE; DIAGNOSTIC IMAGING; EYE FUNDUS; EYE TOXICITY; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMAGING SYSTEM; KIDNEY INJURY; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA MACULA CYSTOID EDEMA; RETINOPATHY; SCREENING; VISUAL IMPAIRMENT;

EID: 33746694821     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9283-z     Document Type: Erratum

References (5)

1. Gualino V, Cohen S, Delyfer M, Sahel J, Gaudric A: Optical coherence tomography findings in tamoxifen retinopathy. Am J Ophthalmol 140: 757-758, 2005
2. Heier J, Dragoo R, Enzenauer R, Waterhouse W: Screening for ocular toxicity in asymptomatic patients treated tamoxifen. Am J Ophthalmol 117: 112-113, 1994
3. Kaiser Kupfer M, Kupfer C, Rodrigues M: Tamoxifen retinopathy. A clinicopathologic report. Ophthalmology 88: 89-93, 1981
4. Pierre-Kahn V, Tadayoni R, Haouchine B, Massin P, Gaudric A: Comparison of optical coherence tomography models OCT1 and Stratus OCT for macular retinal thickness measurement. Br J Ophthalmol 89: 1581-1585, 2005
5. Mäenpää H, Mannerström M, Toimela T, Saminen L, Saransaari P, Tahti H: Glutamate uptake is inhibited by tamoxifen and toremifene in cultured retinal pigment epithelial cells. Pharmacol Toxicol 91: 116-122, 2002